Stellar Biotechnologies Inc (SBOT) Stock Faces Higher Risks Forward After Forming Bearish Double Bottom Pattern

September 17, 2017 - By Marry Poplack

The chart of Stellar Biotechnologies Inc (SBOT) shows a double bottom with $1.06 target or 9.00 % below today’s $1.16 share price. The 5 months chart pattern indicates high risk for the $12.22M company. It was reported on Sep, 17 by Finviz.com. If the $1.06 price target is reached, the company will be worth $1.10M less. Double bottoms are rare but powerful chart patterns.

The stock 0.14% or $0 on September 15, reaching $1.16. It is down 60.19% since September 17, 2016 and is downtrending. It has underperformed by 76.89% the S&P500.

Analysts expect Stellar Biotechnologies Inc (NASDAQ:SBOT) to report $-0.14 EPS on December, 13.They anticipate $0.01 EPS change or 7.69 % from last quarter’s $-0.13 EPS. After having $-0.12 EPS previously, Stellar Biotechnologies Inc’s analysts see 16.67 % EPS growth.

More notable recent Stellar Biotechnologies Inc (NASDAQ:SBOT) news were published by: Marketwatch.com which released: “1.16” on November 05, 2015, also Marketwired.com with their article: “Stellar Biotechnologies and Neovacs Announce Formation of New Company Neostell …” published on July 19, 2016, Globenewswire.com published: “Neovacs Associates Stellar Biotechnologies in Its Industrial Project” on January 21, 2016. More interesting news about Stellar Biotechnologies Inc (NASDAQ:SBOT) were released by: Marketwired.com and their article: “Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region” published on January 11, 2017 as well as Barrons.com‘s news article titled: “Stellar Biotechnologies Gets a Positive Sign” with publication date: February 25, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.